|
|
Last Modified: 5/31/2007  First Published: 8/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
RWMC-0633846 NCT00022230
|
|
|
|
|
|
|
|
Last Modified: 12/31/2007  First Published: 2/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
STLMC-IMM-0104 STLMC-L-01108, NCI-V01-1686, NCT00030342
|
|
|
|
|
|
|
|
Last Modified: 10/17/2003  First Published: 10/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
18 to 80
|
|
|
|
Other
|
|
|
|
MSGCC-0065 UPCC-6401, NCI-V02-1709, NCT00046852
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 to 75
|
|
|
|
Other
|
|
|
|
rM28-001 NCT00204594
|
|
|
|
|
|
|
|
Last Modified: 10/10/2008  First Published: 10/30/2007 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 to 75
|
|
|
|
NCI
|
|
|
|
FHCRC-2179.00 FHCRC-2179.00, NCT00553306
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
Over 16
|
|
|
|
Other
|
|
|
|
STLMC-BRM-9401 NCI-V94-0514, NCT00002589
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
NCI-95-C-0105A NCI-T94-0096N, T94-0096, NCT00019084
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
30 and under
|
|
|
|
NCI
|
|
|
|
NCI-97-C-0050K NCI-T96-0037, T96-0037, NCT00019279
|
|
|
|
|
|
|
|
Last Modified: 5/22/2007  First Published: 3/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
Not specified
|
|
|
|
Other
|
|
|
|
MSGCC-9851 MSGCC-1198006, NCI-V98-1513, NCT00003727
|
|
|
|
|
|
|
|
Last Modified: 5/25/2005  First Published: 9/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
WSU-C-1403-BR NCI-G99-1561, NCT00004018
|
|
|
|